| NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors GD Demetri, M Von Mehren, CR Antonescu, RP DeMatteo, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 8 (Suppl_2), S-1-S-41, 2010 | 1314 | 2010 |
| Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ... The Lancet Oncology 18 (11), 1493-1501, 2017 | 1209 | 2017 |
| Comprehensive and integrated genomic characterization of adult soft tissue sarcomas AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ... Cell 171 (4), 950-965, 2017 | 877 | 2017 |
| Genomic signatures to guide the use of chemotherapeutics A Potti, HK Dressman, A Bild, RF Riedel, G Chan, R Sayer, J Cragun, ... Nature medicine 12 (11), 1294-1300, 2006 | 691 | 2006 |
| Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development NC Luetteke, TH Qiu, SE Fssssenton, KL Troyer, RF Riedel, A Chang, ... Development 126 (12), 2739-2750, 1999 | 670 | 1999 |
| Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology M Von Mehren, RL Randall, RS Benjamin, S Boles, MM Bui, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 16 (5), 536-563, 2018 | 640 | 2018 |
| Sorafenib for advanced and refractory desmoid tumors MM Gounder, MR Mahoney, BA Van Tine, V Ravi, S Attia, HA Deshpande, ... New England Journal of Medicine 379 (25), 2417-2428, 2018 | 407 | 2018 |
| Soft tissue sarcoma, version 2.2016, NCCN clinical practice guidelines in oncology M Von Mehren, RL Randall, RS Benjamin, S Boles, MM Bui, EU Conrad, ... Journal of the National Comprehensive Cancer Network 14 (6), 758-786, 2016 | 324 | 2016 |
| Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre … WD Tap, Z Papai, BA Van Tine, S Attia, KN Ganjoo, RL Jones, S Schuetze, ... The lancet oncology 18 (8), 1089-1103, 2017 | 287 | 2017 |
| Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients … GD Demetri, SP Chawla, I Ray-Coquard, A Le Cesne, AP Staddon, ... Journal of Clinical Oncology 31 (19), 2485-2492, 2013 | 275 | 2013 |
| A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer MJ Whitley, DM Cardona, AL Lazarides, I Spasojevic, JM Ferrer, J Cahill, ... Science translational medicine 8 (320), 320ra4-320ra4, 2016 | 256 | 2016 |
| NCCN guidelines insights: soft tissue sarcoma, version 1.2021: featured updates to the NCCN guidelines M von Mehren, JM Kane, MM Bui, E Choy, M Connelly, S Dry, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 18 (12), 1604-1612, 2020 | 251 | 2020 |
| Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma LE Davis, V Bolejack, CW Ryan, KN Ganjoo, ET Loggers, S Chawla, ... Journal of Clinical Oncology 37 (16), 1424-1431, 2019 | 225 | 2019 |
| Effects of enhanced caregiver training program on cancer caregiver’s self-efficacy, preparedness, and psychological well-being CC Hendrix, DE Bailey, KE Steinhauser, MK Olsen, KM Stechuchak, ... Supportive Care in Cancer 24, 327-336, 2016 | 216 | 2016 |
| Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology M von Mehren, JM Kane, M Agulnik, MM Bui, J Carr-Ascher, E Choy, ... Journal of the National Comprehensive Cancer Network 20 (7), 815-833, 2022 | 199 | 2022 |
| The clinical management of chondrosarcoma RF Riedel, N Larrier, L Dodd, D Kirsch, S Martinez, BE Brigman Current treatment options in oncology 10, 94-106, 2009 | 185 | 2009 |
| Soft tissue sarcoma GD Demetri, S Antonia, RS Benjamin, MM Bui, ES Casper, EU Conrad, ... Journal of the National Comprehensive Cancer Network 8 (6), 630-674, 2010 | 171 | 2010 |
| Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines M Von Mehren, RS Benjamin, MM Bui, ES Casper, EU Conrad, ... Journal of the National Comprehensive Cancer Network 10 (8), 951-960, 2012 | 165 | 2012 |
| Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab EZ Keung, M Burgess, R Salazar, ER Parra, J Rodrigues-Canales, ... Clinical Cancer Research 26 (6), 1258-1266, 2020 | 154 | 2020 |
| Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant P Salomoni, MA Wasik, RF Riedel, K Reiss, JK Choi, T Skorski, ... The Journal of experimental medicine 187 (12), 1995-2007, 1998 | 141 | 1998 |
